Literature DB >> 25912030

A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation.

Tobias Pasqualon1, Jessica Pruessmeyer1, Sarah Weidenfeld1, Aaron Babendreyer1, Esther Groth1, Julian Schumacher1, Nicole Schwarz2, Bernd Denecke3, Holger Jahr4, Pascale Zimmermann5,6, Daniela Dreymueller1, Andreas Ludwig7.   

Abstract

Syndecan-1 is a heparan sulfate proteoglycan expressed by endothelial and epithelial cells and involved in wound healing and tumor growth. Surface-expressed syndecan-1 undergoes proteolytic shedding leading to the release of the soluble N-terminal ectodomain from a transmembrane C-terminal fragment (tCTF). We show that the disintegrin and metalloproteinase (ADAM) 17 generates a syndecan-1 tCTF, which can then undergo further intra-membrane proteolysis by γ-secretase. Scratch-induced wound closure of cultured lung epithelial A549 tumor cells associates with increased syndecan-1 cleavage as evidenced by the release of shed syndecan-1 ectodomain and enhanced generation of the tCTF. Both wound closure and the associated syndecan-1 shedding can be suppressed by inhibition of ADAM family proteases. Cell proliferation, migration and invasion into matrigel as well as several signaling pathways implicated in these responses are suppressed by silencing of syndecan-1. These defects of syndecan-1 deficient cells can be overcome by overexpression of syndecan-1 tCTF or a corresponding tCTF of syndecan-4 but not by overexpression of a tCTF lacking the transmembrane domain. Finally, lung metastasis formation of A549 cells in SCID mice was found to be dependent on syndecan-1, and the presence of syndecan-1 tCTF was sufficient for this activity. Thus, the syndecan-1 tCTF by itself is capable of mediating critical syndecan-1-dependent functions in cell proliferation, migration, invasion and metastasis formation and therefore can replace full length syndecan-1 in the situation of increased syndecan-1 shedding during cell migration and tumor formation.

Entities:  

Keywords:  Lung metastasis formation; Shedding; Syndecan-1; Tumor cell migration

Mesh:

Substances:

Year:  2015        PMID: 25912030     DOI: 10.1007/s00018-015-1912-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  49 in total

1.  Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts.

Authors:  V Lories; J J Cassiman; H Van den Berghe; G David
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

Review 2.  Syndecans: new kids on the signaling block.

Authors:  Eugene Tkachenko; John M Rhodes; Michael Simons
Journal:  Circ Res       Date:  2005-03-18       Impact factor: 17.367

3.  Regulated shedding of syndecan ectodomains by chemokines.

Authors:  Nathalie Charnaux; Angela Sutton; Severine Brule; Liliane Gattegno
Journal:  ScientificWorldJournal       Date:  2006-08-25

Review 4.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

5.  Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration.

Authors:  Y Gao; M Li; W Chen; M Simons
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

Review 6.  Syndecans play dual roles as cell adhesion receptors and docking receptors.

Authors:  Mi-Jung Kwon; Bohee Jang; Jae Youn Yi; Inn-Oc Han; Eok Soo Oh
Journal:  FEBS Lett       Date:  2012-05-31       Impact factor: 4.124

Review 7.  A genecentric Human Protein Atlas for expression profiles based on antibodies.

Authors:  Lisa Berglund; Erik Björling; Per Oksvold; Linn Fagerberg; Anna Asplund; Cristina Al-Khalili Szigyarto; Anja Persson; Jenny Ottosson; Henrik Wernérus; Peter Nilsson; Emma Lundberg; Asa Sivertsson; Sanjay Navani; Kenneth Wester; Caroline Kampf; Sophia Hober; Fredrik Pontén; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2008-10       Impact factor: 5.911

8.  Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling.

Authors:  Joachim G Schulz; Wim Annaert; Joël Vandekerckhove; Pascale Zimmermann; Bart De Strooper; Guido David
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

9.  Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function.

Authors:  S F Penc; B Pomahac; T Winkler; R A Dorschner; E Eriksson; M Herndon; R L Gallo
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.

Authors:  Bálint Péterfia; Tibor Füle; Kornélia Baghy; Krisztina Szabadkai; Alexandra Fullár; Katalin Dobos; Fang Zong; Katalin Dobra; Péter Hollósi; András Jeney; Sándor Paku; Ilona Kovalszky
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

View more
  12 in total

Review 1.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

2.  A cytoplasmic C-terminal fragment of Syndecan-1 is generated by sequential proteolysis and antagonizes Syndecan-1 dependent lung tumor cell migration.

Authors:  Tobias Pasqualon; Jessica Pruessmeyer; Vera Jankowski; Aaron Babendreyer; Esther Groth; Julian Schumacher; Andrea Koenen; Sarah Weidenfeld; Nicole Schwarz; Bernd Denecke; Holger Jahr; Daniela Dreymueller; Joachim Jankowski; Andreas Ludwig
Journal:  Oncotarget       Date:  2015-10-13

3.  Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate.

Authors:  Franck Madoux; Daniela Dreymuller; Jean-Phillipe Pettiloud; Radleigh Santos; Christoph Becker-Pauly; Andreas Ludwig; Gregg B Fields; Thomas Bannister; Timothy P Spicer; Mare Cudic; Louis D Scampavia; Dmitriy Minond
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

Review 4.  Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.

Authors:  D Dreymueller; K Theodorou; M Donners; A Ludwig
Journal:  Mediators Inflamm       Date:  2017-02-05       Impact factor: 4.711

5.  Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Authors:  Sherif Abdelaziz Ibrahim; Ramy Gadalla; Eslam A El-Ghonaimy; Omnia Samir; Hossam Taha Mohamed; Hebatallah Hassan; Burkhard Greve; Mohamed El-Shinawi; Mona Mostafa Mohamed; Martin Götte
Journal:  Mol Cancer       Date:  2017-03-07       Impact factor: 27.401

6.  Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.

Authors:  Ivana Miše; Majda Vučić
Journal:  Anal Cell Pathol (Amst)       Date:  2018-07-29       Impact factor: 2.916

7.  Analysis of mutations in primary and metastatic synovial sarcoma.

Authors:  Zhuo Xing; Lei Wei; Xiaoling Jiang; Jeffrey Conroy; Sean Glenn; Wiam Bshara; Tao Yu; Annie Pao; Shinya Tanaka; Akira Kawai; Christopher Choi; Jianmin Wang; Song Liu; Carl Morrison; Y Eugene Yu
Journal:  Oncotarget       Date:  2018-12-07

Review 8.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

9.  iRhom2 in the pathogenesis of oral squamous cell carcinoma.

Authors:  Matthew E Agwae; Richard J Shaw; Asterios Triantafyllou; Frances S T Greaney; Khaled Ben Salah; Janet M Risk
Journal:  Mol Biol Rep       Date:  2020-03-31       Impact factor: 2.316

10.  Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.

Authors:  Li Luo; Siqi Feng; Yao Wu; Ya Su; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Infect Dis J       Date:  2019-01       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.